Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




System Tracks Location of Blood Bank Coolers in Real Time

By LabMedica International staff writers
Posted on 16 Aug 2011
A tracking system that can significantly aid in the successful conservation of stored blood has been developed especially for hospitals. More...


The technology tracks the location and elapsed time-in-use of the portable coolers that blood banks use to transport blood and blood products to where they are needed throughout the hospital.

This innovative system employs Real-Time Location System (RTLS) technology, and was developed for Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) and launched in August 2010. By tracking the location and elapsed time of coolers and electronically conveying that information to the appropriate personnel, the new system allows staff members to retrieve coolers containing unused blood before their specified time expires, thus greatly reducing the possibility that unused blood may have to be destroyed.

Proprietary RTLS tags are affixed to the exteriors of portable coolers; the tracking system's software displays each cooler's status on a computer monitor. When a cooler's status changes, the system changes the color of that cooler's screen icon and automatically sends an email notice to designated addresses. On the "status board" on the computer monitor, a green icon indicates that a cooler is ready for use. When a full cooler is removed from the blood bank, its icon changes to blue, and its movement is tracked and a timing process is initiated. Fifteen minutes before the cooler reaches its effective time limit, its icon changes to yellow and an email is sent. If a cooler is still out when its effective time expires, the icon turns orange and another message is sent. Fifteen minutes past the cooler's time limit, its icon changes to red, and a final email notice goes out. When the cooler is returned and processed in the blood bank, the system resets its status to "ready for use."

Mary Rose Jones, manager of the blood bank said, "Since adopting the RTLS system last August, the results have been outstanding. We have not lost one cooler in the Medical Center. We also have reduced labor time Blood Bank staff members no longer have to make multiple phone calls in trying to locate coolers and realized considerable dollar savings." Wake Forest Baptist has filed a provisional application for a patent on the tracking system and has formed a company, called Time Temp Trac (Winston-Salem, NC, USA) that will market the system to hospitals and other health care facilities.

Related Links:
Wake Forest Baptist Medical Center
Time Temp Trac


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.